Global Lipid Disorder Treatment Market Report By Drug Type (Atorvastatin, Fluvastatin, Rosuvastatin, Simvastatin, Pravastatin, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Indication (Familial Combined Hyperlipidemia, Familial Defective Apolipoprotein B-100, Familial Dysbetalipoproteinemia, Familial Hypertriglyceridemia, Heterozygous Familial Hypercholesterolemia, Others), And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11212596
June 2020
Report Formats:
The global demand for Lipid Disorder Treatment Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
 
Lipid disorder is a metabolic condition that affects blood lipid levels. The condition causes high blood levels of low-density lipoprotein (LDL) cholesterol, and fats called triglycerides or both. High levels of LDL cholesterol and triglycerides increase the risk of developing heart disease. These levels can be reduced by some primary options such as eating less fat, exercising regularly and losing weight if one is obese. However, these options are not always effective. In such cases medication is prescribed to control the level, medications, such as statins, are effective in lowering cholesterol levels for many patients. Other medications, including bile acid sequestrants, fibric acid derivatives, cholesterol absorption inhibitors, and niacin can also help control lipid levels.
 
Market Dynamics
 
The rising global burden and growing geriatric population will be driving the growth of the market. The increasing prevalence of lipid disorders has become a global public health problem. In 2017, 4.32 million deaths were estimated owing to high low-density lipoprotein cholesterol globally. Globally geriatric population who are more prevelant to lipipd disorder is growing considerably faster than the population as a whole, and it is expected to continue growing more rapidly at least till 2050. Apart from ageing, gender, genetic susceptibility, chronic diseases, medications, certain lifestyles including excessive intake of foods high in saturated or trans fats, physical inactivity, obesity and smoking also contribute to blood lipid disorders. To bring awareness about prevention, management, and treatment of blood lipid disorders, the Government is promoting a healthy diet and physical activity participation, early detection and management of blood lipid disorders as well as update and review of drug lists and clinical protocols regularly to ensure impartial access to drugs and therapies of proven safety and efficacy. The overall scenario is predicted to make healthy growth of the market.
 
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of Lipid Disorder Treatment.
 
Market Segmentation
 
The entire Lipid Disorder Treatment market has been sub-categorized into drug type, distribution channel, and indication. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 
By Drug Type
  • Atorvastatin
  • Fluvastatin
  • Rosuvastatin
  • Simvastatin
  • Pravastatin
  • Other
 
By Distribution Channel
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
 
By Indication
  • Familial Combined Hyperlipidemia
  • Familial Defective Apolipoprotein B-100
  • Familial Dysbetalipoproteinemia
  • Familial Hypertriglyceridemia
  • Heterozygous Familial Hypercholesterolemia
  • Others
 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for Lipid Disorder Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Europe Lipid Disorder Treatment Market By Revenue (USD MN)
 

 
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Lipid Disorder Treatment market include Pfizer, Inc, Novartis AG, Astrazeneca Plc, Merck and Co., Emcure Pharmaceuticals Ltd. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
                                          
METHODOLOGY:
 
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
 
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Lipid Disorder Treatment Market
       2.2. Global Lipid Disorder Treatment Market Snapshot
 
3 . LIPID DISORDER TREATMENT – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Lipid Disorder Treatment Market
       3.3. Market Restraints of Lipid Disorder Treatment Market
       3.4. Opportunities of Lipid Disorder Treatment Market
       3.5. Trends of Lipid Disorder Treatment Market
       3.6. Porter’s Five Force Analysis of Lipid Disorder Treatment Market
       3.7. Lipid Disorder Treatment Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Drug Type
           3.7.2 Market Attractive Analysis by Distribution Channel
           3.7.3 Market Attractive Analysis by Indication
           3.7.4 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Lipid Disorder Treatment Value Chain Analysis
       4.2. Lipid Disorder Treatment Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Lipid Disorder Treatment Raw Material Manufactures List
           4.2.3. Price Trend of Lipid Disorder Treatment Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Lipid Disorder Treatment Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Lipid Disorder Treatment Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Lipid Disorder Treatment Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Lipid Disorder Treatment Market
 
6 . GLOBAL LIPID DISORDER TREATMENT MARKET ANALYSIS BY DRUG TYPE
       6.1 Overview by Drug Type
       6.2 Global Lipid Disorder Treatment Market Analysis by Drug Type
       6.3 Market Analysis of Atorvastatin by Regions
       6.4 Market Analysis of Fluvastatin by Regions
       6.6 Market Analysis of Rosuvastatin by Regions
       6.5 Market Analysis of Simvastatin by Regions
       6.7 Market Analysis of Pravastatin by Regions
       6.8 Market Analysis of Other by Regions
 
7 . GLOBAL LIPID DISORDER TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL
       7.1 Overview by Distribution Channel
       7.2 Global Lipid Disorder Treatment Market Analysis by Distribution Channel
       7.3 Market Analysis of Retail Pharmacies by Regions
       7.4 Market Analysis of Hospital Pharmacies by Regions
       7.5 Market Analysis of Online Pharmacies by Regions
 
8 . GLOBAL LIPID DISORDER TREATMENT MARKET ANALYSIS BY INDICATION
       8.1 Overview by Indication
       8.2 Global Lipid Disorder Treatment Market Analysis by Indication
       8.3 Market Analysis of Familial Combined Hyperlipidemia by Regions
       8.4 Market Analysis of Familial Defective Apolipoprotein B-100 by Regions
       8.5 Market Analysis of Familial Dysbetalipoproteinemia by Regions
       8.6 Market Analysis of Familial Hypertriglyceridemia by Regions
       8.7 Market Analysis of Heterozygous Familial Hypercholesterolemia by Regions
       8.8 Market Analysis of Others by Regions
 
9 . GLOBAL LIPID DISORDER TREATMENT MARKET ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook
       9.2. Introduction
       9.3. North America
           9.3.1. Overview
           9.3.2. North America Lipid Disorder Treatment Market Estimate by Country
           9.3.3. United State
           9.3.4. Rest of North America
       9.4. Europe
           9.4.1. Overview
           9.4.2. Europe Lipid Disorder Treatment Market Estimate by Market Segment
           9.4.3. Europe Lipid Disorder Treatment Market Estimate by Country
           9.4.4. United Kingdom
           9.4.5. France
           9.4.6. Germany
           9.4.7 Rest of Europe
       9.5. Asia Pacific
           9.5.1. Overview
           9.5.2. Asia Pacific Lipid Disorder Treatment Market Estimate by Market Segment
           9.5.3. Asia Pacific Lipid Disorder Treatment Market Estimate by Country
           9.5.4. China
           9.5.5. Japan
           9.5.6. India
           9.5.7. Rest of Asia Pacific
       9.6. Latin America
           9.6.1. Overview
           9.6.2. Latin America Lipid Disorder Treatment Market Estimate by Market Segment
           9.6.3. Latin America Lipid Disorder Treatment Market Estimate by Country
           9.6.4. Brazil
           9.6.5. Rest of Latin America
       9.7. Middle East & Africa
           9.7.1. Overview
           9.7.2. Middle East & Africa Lipid Disorder Treatment Market Estimate by Market Segment
           9.7.3. Middle East & Africa Lipid Disorder Treatment Market Estimate by Country
           9.7.4. Middle East
           9.7.5. Africa
 
10 . COMPETITIVE LANDSCAPE OF THE LIPID DISORDER TREATMENT COMPANIES
       10.1. Lipid Disorder Treatment Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments
 
11 . COMPANY PROFILES OF LIPID DISORDER TREATMENT INDUSTRY
       11.1. Company Share Analysis
       11.2. Market Concentration Rate
       11.3. Pfizer, Inc.
           11.3.1. Company Overview
           11.3.2. Financials
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. Novartis AG
           11.4.1. Company Overview
           11.4.2. Financials
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. Astrazeneca Plc
           11.5.1. Company Overview
           11.5.2. Financials
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. Merck and Co.
           11.6.1. Company Overview
           11.6.2. Financials
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. Emcure Pharmaceuticals Ltd.
           11.7.1. Company Overview
           11.7.2. Financials
           11.7.3. Products
           11.7.4. Recent Developments
 
 *Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Lipid Disorder Treatment Market Snapshot
  • Drivers of The Global Lipid Disorder Treatment Market Impact Analysis
  • Restraints of The Global Lipid Disorder Treatment Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Lipid Disorder Treatment Market: Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Lipid Disorder Treatment Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on Lipid Disorder Treatment Market
  • Global Lipid Disorder Treatment Market Analysis by Drug Type (USD MN)
  • Global Lipid Disorder Treatment Market Analysis in Atorvastatin by Geography (USD MN)
  • Global Lipid Disorder Treatment Market Analysis in Fluvastatin by Geography (USD MN)
  • Global Lipid Disorder Treatment Market Analysis in Rosuvastatin by Geography (USD MN)
  • Global Lipid Disorder Treatment Market Analysis in Simvastatin by Geography (USD MN)
  • Global Lipid Disorder Treatment Market Analysis in Pravastatin by Geography (USD MN)
  • Global Lipid Disorder Treatment Market Analysis in Other by Geography (USD MN)
  • Global Lipid Disorder Treatment Market Analysis by Distribution Channel (USD MN)
  • Global Lipid Disorder Treatment Market Analysis in Retail Pharmacies by Geography (USD MN)
  • Global Lipid Disorder Treatment Market Analysis in Hospital Pharmacies by Geography (USD MN)
  • Global Lipid Disorder Treatment Market Analysis in Online Pharmacies by Geography (USD MN)
  • Global Lipid Disorder Treatment Market Analysis by Indication (USD MN)
  • Global Lipid Disorder Treatment Market Analysis in Familial Combined Hyperlipidemia by Geography (USD MN)
  • Global Lipid Disorder Treatment Market Analysis in Familial Defective Apolipoprotein B-100 by Geography (USD MN)
  • Global Lipid Disorder Treatment Market Analysis in Familial Dysbetalipoproteinemia by Geography (USD MN)
  • Global Lipid Disorder Treatment Market Analysis in Familial Hypertriglyceridemia by Geography (USD MN)
  • Global Lipid Disorder Treatment Market Analysis in Heterozygous Familial Hypercholesterolemia by Geography (USD MN)
  • Global Lipid Disorder Treatment Market Analysis in Others by Geography (USD MN)
  • Global Lipid Disorder Treatment Market by Geography (USD MN)
  • North America Lipid Disorder Treatment Market Analysis by Drug Type (USD MN)
  • North America Lipid Disorder Treatment Market Estimate by Distribution Channel (USD MN)
  • North America Lipid Disorder Treatment Market Estimate by Indication (USD MN)
  • North America Lipid Disorder Treatment Market Estimate by Country (USD MN)
  • United State Lipid Disorder Treatment Market Analysis by Drug Type (USD MN)
  • United State Lipid Disorder Treatment Market Estimate by Distribution Channel (USD MN)
  • United State Lipid Disorder Treatment Market Analysis by Indication (USD MN)
  • Rest of North America Lipid Disorder Treatment Market Analysis by Drug Type (USD MN)
  • Rest of North America Lipid Disorder Treatment Market Estimate by Distribution Channel (USD MN)
  • Rest of North America Lipid Disorder Treatment Market Estimate by Indication(USD MN)
  • Europe Lipid Disorder Treatment Market Analysis by Drug Type (USD MN)
  • Europe Lipid Disorder Treatment Market Estimate by Distribution Channel (USD MN)
  • Europe Lipid Disorder Treatment Market Estimate by Indication (USD MN)
  • United Kingdom Lipid Disorder Treatment Market Analysis by Drug Type (USD MN)
  • United Kingdom Lipid Disorder Treatment Market Estimate by Distribution Channel (USD MN)
  • United Kingdom Lipid Disorder Treatment Market Estimate by Indication (USD MN)
  • France Lipid Disorder Treatment Market Analysis by Drug Type (USD MN)
  • France Lipid Disorder Treatment Market Estimate by Distribution Channel (USD MN)
  • France Lipid Disorder Treatment Market Estimate by Indication (USD MN)
  • Germany Lipid Disorder Treatment Market Analysis by Drug Type (USD MN)
  • Germany Lipid Disorder Treatment Market Estimate by Distribution Channel (USD MN)
  • Germany Lipid Disorder Treatment Market Estimate by Indication (USD MN)
  • Rest of Europe Lipid Disorder Treatment Market Analysis by Drug Type (USD MN)
  • Rest of Europe Lipid Disorder Treatment Market Estimate by Distribution Channel (USD MN)
  • Rest of Europe Lipid Disorder Treatment Market Estimate by Indication (USD MN)
  • Asia Pacific Lipid Disorder Treatment Market Analysis by Drug Type (USD MN)
  • Asia Pacific Lipid Disorder Treatment Market Estimate by Distribution Channel (USD MN)
  • Asia Pacific Lipid Disorder Treatment Market Estimate by Indication (USD MN)
  • Asia Pacific Lipid Disorder Treatment Market Estimate by Country (USD MN)
  • China Lipid Disorder Treatment Market Analysis by Drug Type (USD MN)
  • China Lipid Disorder Treatment Market Estimate by Distribution Channel (USD MN)
  • China Lipid Disorder Treatment Market Estimate by Indication (USD MN)
  • Japan Lipid Disorder Treatment Market Analysis by Drug Type (USD MN)
  • Japan Lipid Disorder Treatment Market Estimate by Distribution Channel (USD MN)
  • Japan Lipid Disorder Treatment Market Estimate by Indication (USD MN)
  • India Lipid Disorder Treatment Market Analysis by Drug Type (USD MN)
  • India Lipid Disorder Treatment Market Estimate by Distribution Channel (USD MN)
  • India Lipid Disorder Treatment Market Estimate by Indication (USD MN)
  • Rest of Asia Pacific Lipid Disorder Treatment Market Analysis by Drug Type (USD MN)
  • Rest of Asia Pacific Lipid Disorder Treatment Market Estimate by Distribution Channel (USD MN)
  • Rest of Asia Pacific Lipid Disorder Treatment Market Estimate by Indication (USD MN)
  • Latin America Lipid Disorder Treatment Market Analysis by Drug Type (USD MN)
  • Latin America Lipid Disorder Treatment Market Estimate by Distribution Channel (USD MN)
  • Latin America Lipid Disorder Treatment Market Estimate by Indication (USD MN)
  • Latin America Lipid Disorder Treatment Market Estimate by Country (USD MN)
  • Brazil Lipid Disorder Treatment Market Analysis by Drug Type (USD MN)
  • Brazil Lipid Disorder Treatment Market Estimate by Distribution Channel (USD MN)
  • Brazil Lipid Disorder Treatment Market Estimate by Indication (USD MN)
  • Rest of Latin America Lipid Disorder Treatment Market Analysis by Drug Type (USD MN)
  • Rest of Latin America Lipid Disorder Treatment Market Estimate by Distribution Channel (USD MN)
  • Rest of Latin America Lipid Disorder Treatment Market Estimate by Indication (USD MN)
  • Middle East & Africa Lipid Disorder Treatment Market Analysis by Drug Type (USD MN)
  • Middle East & Africa Lipid Disorder Treatment Market Estimate by Distribution Channel (USD MN)
  • Middle East & Africa Lipid Disorder Treatment Market Estimate by Indication (USD MN)
  • Middle East & Africa Lipid Disorder Treatment Market Estimate by Country (USD MN)
  • Middle East Lipid Disorder Treatment Market Analysis by Drug Type (USD MN)
  • Middle East Lipid Disorder Treatment Market Estimate by Distribution Channel (USD MN)
  • Middle East Lipid Disorder Treatment Market Estimate by Indication (USD MN)
  • Africa Lipid Disorder Treatment Market Analysis by Drug Type (USD MN)
  • Africa Lipid Disorder Treatment Market Estimate by Distribution Channel (USD MN)
  • Africa Lipid Disorder Treatment Market Estimate by Indication (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
 
  • Research Scope of Lipid Disorder Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Lipid Disorder Treatment Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Drug Type
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Indication
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Lipid Disorder Treatment Market Analysis by Drug Type (USD MN)
  • Global Lipid Disorder Treatment Market Analysis in Atorvastatin by Geography (USD MN)
  • Global Lipid Disorder Treatment Market Analysis in Fluvastatin by Geography (USD MN)
  • Global Lipid Disorder Treatment Market Analysis in Rosuvastatin by Geography (USD MN)
  • Global Lipid Disorder Treatment Market Analysis in Simvastatin by Geography (USD MN)
  • Global Lipid Disorder Treatment Market Analysis in Pravastatin by Geography (USD MN)
  • Global Lipid Disorder Treatment Market Analysis in Other by Geography (USD MN)
  • Global Lipid Disorder Treatment Market Analysis by Distribution Channel (USD MN)
  • Global Lipid Disorder Treatment Market Analysis in Retail Pharmacies by Geography (USD MN)
  • Global Lipid Disorder Treatment Market Analysis in Hospital Pharmacies by Geography (USD MN)
  • Global Lipid Disorder Treatment Market Analysis in Online Pharmacies by Geography (USD MN)
  • Global Lipid Disorder Treatment Market Analysis by Indication (USD MN)
  • Global Lipid Disorder Treatment Market Analysis in Familial Combined Hyperlipidemia by Geography (USD MN)
  • Global Lipid Disorder Treatment Market Analysis in Familial Defective Apolipoprotein B-100 by Geography (USD MN)
  • Global Lipid Disorder Treatment Market Analysis in Familial Dysbetalipoproteinemia by Geography (USD MN)
  • Global Lipid Disorder Treatment Market Analysis in Familial Hypertriglyceridemia by Geography (USD MN)
  • Global Lipid Disorder Treatment Market Analysis in Heterozygous Familial Hypercholesterolemia by Geography (USD MN)
  • Global Lipid Disorder Treatment Market Analysis in Others by Geography (USD MN)
  • Latin America Lipid Disorder Treatment Market by Revenue
  • Middle East & Africa Lipid Disorder Treatment Market by Revenue
  • Recent Development in Lipid Disorder Treatment Industry
  • Company Market Share Analysis, 2019
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials